Hyundai Bioscience Market Cap

Hyundai Bioscience has a market cap or net worth of 497.47 billion as of November 4, 2025. Its market cap has decreased by -34.69% in one year.

Market Cap

497.47B

Enterprise Value

465.29B

Revenue

1.87B

Ranking

n/a

PE Ratio

n/a

Stock Price

5,340.00

Market Cap Chart

Since March 3, 2003, Hyundai Bioscience's market cap has increased from 47.49B to 497.47B, an increase of 947.43%. That is a compound annual growth rate of 10.91%.

Market Cap History

Date	Market Cap	% Change
Nov 3, 2025	497.47B	-11.46%
Dec 30, 2024	561.85B	-45.92%
Dec 28, 2023	1.04T	-4.44%
Dec 29, 2022	1.09T	11.39%
Dec 30, 2021	976.10B	-6.92%
Dec 30, 2020	1.05T	115.45%
Dec 30, 2019	Upgrade Pro	Upgrade Pro
Dec 28, 2018	Upgrade Pro	Upgrade Pro
Dec 28, 2017	Upgrade Pro	Upgrade Pro
Dec 29, 2016	Upgrade Pro	Upgrade Pro
Dec 30, 2015	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Samsung Biologics	86.90T
Celltrion	38.46T
ALTEOGEN	27.97T
SK Biopharmaceuticals	9.30T
Yuhan	8.83T
HLB Co., Ltd.	6.19T
Peptron	6.14T
ABL Bio	5.69T

Market Cap Rankings